MENU
IMVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunovant (IMVT) Earnings Date & Reports

A.I. Advisor
published Earnings

IMVT is expected to report earnings to -74 cents per share on February 12

Immunovant IMVT Stock Earnings Reports
Q4'24
Est.
$-0.74
Q3'24
Missed
by $0.15
Q2'24
Est.
$-0.52
Q1'24
Missed
by $0.09
Q4'23
Beat
by $0.07
The last earnings report on November 07 showed earnings per share of -74 cents, missing the estimate of -58 cents. With 3.24M shares outstanding, the current market capitalization sits at 3.80B.
View a ticker or compare two or three
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
320 West 37th Street
Phone
+1 917 580-3099
Employees
164
Web
https://www.immunovant.com